7. Surgical Management of Sleep-Disordered Breathing

  1. Douglas B. Kirsch MD, FAASM4,5
  1. Takashima Masayoshi MD, FACS, FAAOA1,
  2. Gateno Jaime DDS, MD2,3,
  3. Davis-Malessevich Melinda MD1 and
  4. Busch Robert DMD, MD2

Published Online: 11 OCT 2013

DOI: 10.1002/9781118764152.ch7

Sleep Medicine in Neurology

Sleep Medicine in Neurology

How to Cite

Masayoshi, T., Jaime, G., Melinda, D.-M. and Robert, B. (2013) Surgical Management of Sleep-Disordered Breathing, in Sleep Medicine in Neurology (ed D. B. Kirsch), John Wiley & Sons, Oxford. doi: 10.1002/9781118764152.ch7

Editor Information

  1. 4

    Harvard Medical School, Boston, MA, USA

  2. 5

    Division of Sleep Neurology, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA

Author Information

  1. 1

    The Bobby R Alford Department of Otolaryngology – Head and Neck Surgery, Baylor College of Medicine, USA

  2. 2

    Weill Cornell Medical College, USA

  3. 3

    Oral and Maxillofacial Surgery Department, The Methodist Hospital Physician Organization, USA

Publication History

  1. Published Online: 11 OCT 2013
  2. Published Print: 7 OCT 2013

ISBN Information

Print ISBN: 9781444335514

Online ISBN: 9781118764152



  • sleep disordered breathing;
  • obstructive sleep apnea;
  • central sleep apnea;
  • neurological disorders;
  • stroke;
  • epilepsy;
  • neuromuscular;
  • headache;
  • neurodegenerative;
  • multiple sclerosis


Sleep disordered breathing (SDB) consists of a variety of disorders characterized by respiratory or ventilatory disturbance during sleep, including obstructive (OSA) and central (CSA) sleep apnea. It is estimated that 50%-75% of patients affected by OSA remain undiagnosed, bringing the suspected prevalence as high as 20%. Both OSA and CSA appear to be more prevalent in a variety of neurological disorders. Conversely, SDB treatment is increasingly found to improve outcomes in comorbid neurological subpopulations. Thus neurologists need to maintain a high level of clinical suspicion and screen for SDB in patients with cerebrovascular disease, neuromuscular disorders, epilepsy, multiple sclerosis, neurodegenerative disease, and primary headaches.